Cancers (Nov 2023)
A New Immunotherapy Combination Promises to Improve Survival for Patients with Metastatic Prostate Cancer
Abstract
Prostate cancer (PC) is the second-most prevalent malignancy affecting the male population worldwide [...]
Keywords